Sanofi links with Regeneron in $2.2 bln cancer drug push
July 28, 2015 at 02:42 AM EDT
July 28 (Reuters) - French drugmaker Sanofi said on Tuesday it was committing up to $2.17 billion to a collaboration with its long-time partner Regeneron Pharmaceuticals in the hot area of cancer immunotherapy.
